Aprea Therapeutics

Home » Aprea Therapeutics

IPO

Aprea Therapeutics

Biopharmaceutical

We are a clinical-stage biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein.

Symbol

APRE

Price Range
TBD

Anticipated Shares
TBD

Anticipated Date
TBD

Underwriters
J.P. MORGAN SECURITIES LLC,MORGAN STANLEY & CO. LLC

To view the prospectus for Aprea Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253